Biblio

2019
Wang, R., Yao, X., Li, T., Li, X., Jin, M., Ni, Y., Yuan, W., Xie, X., Lu, L., and Li, M. (2019). Reversible Thermoresponsive Hydrogel Fabricated from Natural Biopolymer for the Improvement of Critical Limb Ischemia by Controlling Release of Stem Cells.Adv Healthc Matere1900967.
Twaroski, K., Eide, C., Riddle, M.J., Xia, L., Lees, C.J., Chen, W., Mathews, W., Keene, D.R., McGrath, J.A., and Tolar, J. (2019). Revertant Mosaic Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa.Br J Dermatol.
Costa, M. (2019). Review of arsenic toxicity, speciation and polyadenylation of canonical histones.Toxicol Appl Pharmacol.
Metzcar, J., Wang, Y., Heiland, R., and Macklin, P. (2019). A Review of Cell-Based Computational Modeling in Cancer Biology.Jco Clin Cancer Inform1-13.
Zhao, J.C., Arnall, J.R., Martin, A.L., Atrash, S., Bhutani, M., Voorhees, P., Avalos, B., Copelan, E., Ghosh, N., Hamadani, M., et al. (2019). A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem-cell Transplant.Biol Blood Marrow Transplant.
Vakilian, M., Tahamtani, Y., and Ghaedi, K. (2019). A review on insulin trafficking and exocytosis.Gene.
Yuan, H., Chen, C., Liu, Y., Lu, T., and Wu, Z. (2019). Review: strategies in cell-free tissue-engineered vascular grafts.J Biomed Mater Res A.
Cook, L.B., Fuji, S., Hermine, O., Bazarbachi, A., Ramos, J.Carlos, Ratner, L., Horwitz, S., Fields, P., Tanase, A., Bumbea, H., et al. (2019). Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.J Clin OncolJCO1800501.
Majeed, A., Harris, Z., Brucks, E., Hinchman, A., Farooqui, A.Ali, Tariq, M.Junaid, Tamizhmani, K., Bin Riaz, I., McBride, A., Latif, A., et al. (2019). Revisiting role of vaccinations in donors, transplant recipients, immunocompromised hosts, travelers and household contacts of stem cell transplant recipients.Biol Blood Marrow Transplant.
Chen, H., Ye, F., and Guo, G. (2019). Revolutionizing immunology with single-cell RNA sequencing.Cell Mol Immunol.
Lee, R.S., Mattar, M.G., Parker, N.F., Witten, I.B., and Daw, N.D. (2019). Reward prediction error does not explain movement selectivity in DMS-projecting dopamine neurons.Elife8.
Moutaoufik, M.Taha, Malty, R., Amin, S., Zhang, Q., Phanse, S., Gagarinova, A., Zilocchi, M., Hoell, L., Minic, Z., Gagarinova, M., et al. (2019). Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.Iscience19, 1114-1132.
Chan, A.K.N., and Chen, C.-W. (2019). Rewiring the Epigenetic Networks in -Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions.Front Cell Dev Biol7, 81.
Philip, D.L., Silantyeva, E.A., Becker, M.L., and Willits, R.K. (2019). RGD-functionalized nanofibers increase early GFAP expression during neural differentiation of mouse embryonic stem cells.Biomacromolecules.
Pennarossa, G., Paffoni, A., Ragni, G., Gandolfi, F., and Brevini, T.A.L. (2019). Rho Signaling-Directed YAP/TAZ Regulation Encourages 3D Spheroid Colony Formation and Boosts Plasticity of Parthenogenetic Stem Cells.Adv Exp Med Biol.
Baek, S.-K., Cho, Y.-S., Kim, I.-S., Jeon, S.-B., Moon, D.-K., Hwangbo, C., Choi, J.-W., Kim, T.-S., and Lee, J.-H. (2019). A Rho-Associated Coiled-Coil Containing Kinase Inhibitor, Y-27632, Improves Viability of Dissociated Single Cells, Efficiency of Colony Formation, and Cryopreservation in Porcine Pluripotent Stem Cells.Cell Reprogram.
(2019). Richter M, Saydaminova K, Yumul R, et al. In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood. 2016;128(18):2206-2217.Blood134, 1482.
Liu, Z., Wang, H., He, J., Yuan, X., and Sun, W. (2019). Rictor ablation in BMSCs inhibits bone metastasis of TM40D cells by attenuating osteolytic destruction and CAF formation.Int J Biol Sci15, 2448-2460.
Ravichandran, M., Lei, R., Tang, Q., Zhao, Y., Lee, J., Ma, L., Chrysanthou, S., Lorton, B.M., Cvekl, A., Shechter, D., et al. (2019). Rinf Regulates Pluripotency Network Genes and Tet Enzymes in Embryonic Stem Cells.Cell Rep28, 1993-2003.e5.
Snowden, J.A., Badoglio, M., and Alexander, T. (2019). The rise of autologous HCT for autoimmune diseases: what's behind it and what does it mean for the future of treatment? A update on behalf of the EBMT Autoimmune Diseases Working Party.Expert Rev Clin Immunol.
Yang, R., Zhang, R., Zhang, Y., Huang, Y., Liang, H., Gui, G., Gong, S., Wang, H., Xu, M., and Fan, J. (2019). Risk Factors Analysis for Human Cytomegalovirus Viremia in Donor+/Recipient+ Hematopoietic Stem Cell Transplantation.Lab Med.
Stemler, J., Salmanton-García, J., Seidel, D., Alexander, B., Bertz, H., Hoenigl, M., Herbrecht, R., Meintker, L., Meißner, A., Mellinghoff, S.C., et al. (2019). Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature.Mycoses.
Fujimoto, A., Hiramoto, N., Yamasaki, S., Inamoto, Y., Uchida, N., Maeda, T., Mori, T., Kanda, Y., Kondo, T., Shiratori, S., et al. (2019). Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Kok, L.M.C., Bungener, L., de Bock, G.H., Biswana, A., van der Wal, G., van Imhoff, G.W., and Bellido, M. (2019). Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.Hum Cell.
Sakaguchi, M., Nakayama, K., Yamaguchi, H., Mii, A., Shimizu, A., Inai, K., Onai, D., Marumo, A., Omori, I., Yamanaka, S., et al. (2019). Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.Acta Haematol1-13.

Pages